NLRP3 and gastric cancer: Thus, the NLRP3 inflammasome promotes gastric cancer and its downregulation by the activity of the aryl hydrocarbon receptor (AhR), dopamine receptor D1 (DRD1) and G protein-coupled bile acid receptor 1, (GPBAR1) may limit the occurrence of pyroptosis, thereby affecting cancer progression (19).